CalciMedica regains Nasdaq MVLS compliance; bid price issue remains

CalciMedica, Inc.

Nasdaq closed MVLS non-compliance after company met alternative stockholders' equity of $5.513M per Q2 10-Q.
Minimum bid price non-compliance still open; deadline Sept 14, 2026 to regain compliance.
Implemented 1-for-5 reverse stock split on Aug 28, 2026 to address bid price.
No assurance of regaining bid price compliance or maintaining other listing requirements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.